Cystic Fibrosis Foundation is the world’s leader in the search for a cure for cystic fibrosis.
The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and to provide all people with the disease the opportunity to lead full, productive lives by funding research and drug development, promoting individualized treatment and ensuring access to high-quality, specialized care.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 18, 2022
Feldan Therapeutics
|
Grant | — | Biotechnology | — |
Dec 29, 2021
EnBiotix
|
Convertable Note | $11M | Biotechnology | — |
May 27, 2021
Metagenomi
|
Grant | $600K | Artificial Intelligence | Yes |
May 13, 2021
Splisense
|
Series B | $28.50M | Biotechnology | Yes |
Jan 15, 2019
Vast Therapeutics
|
Series A | $15M | Biotechnology | — |